LIGAND PHARMACEUTICAL INC (LGNXZ)

USD 0.0

(0.0%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 787.21 Million 762.66 Million 1.29 Billion 1.36 Billion 1.49 Billion 1.31 Billion
Total Current Assets 237.42 Million 263.6 Million 464.75 Million 500.55 Million 1.12 Billion 870.54 Million
Cash And Short Term Investments 170.3 Million 211.87 Million 341.1 Million 411.52 Million 1.07 Billion 767.18 Million
Cash and Cash Equivalents 22.95 Million 45 Million 19.52 Million 47.96 Million 72.27 Million 119.78 Million
Short Term Investments 147.35 Million 166.86 Million 321.58 Million 363.56 Million 998.32 Million 647.4 Million
Net Receivables 39.31 Million 35.03 Million 91.64 Million 59.06 Million 41.74 Million 55.85 Million
Inventory 23.96 Million 13.29 Million 27.32 Million 26.48 Million 7.29 Million 7.12 Million
Other Current Assets 3.83 Million 3.39 Million 4.67 Million 3.47 Million 4 Million 40.37 Million
Total Non-Current Assets 549.78 Million 499.06 Million 832.83 Million 861.72 Million 371.27 Million 442.22 Million
Net PPE 25.06 Million 27.49 Million 32.6 Million 37.16 Million 17.53 Million 5.37 Million
Good Will And Intangible Assets 470.26 Million 105.67 Million 732.24 Million 784.99 Million 305.67 Million 306.43 Million
Good Will 103.37 Million 105.67 Million 105.67 Million 189.66 Million 95.22 Million 86.64 Million
Intangible Assets 366.89 Million - 551.04 Million 595.33 Million 210.44 Million 219.79 Million
Long-Term Investments 48.32 Million 352.63 Million -239.77 Million -24.32 Million 20.09 Million 31.46 Million
Tax Assets 214 Thousand 8.53 Million 35.72 Million 24.32 Million 25.6 Million 98.48 Million
Other Non Current Assets 5.92 Million 4.73 Million 272.03 Million 39.56 Million 2.35 Million 471 Thousand
Other Assets - - - - - -
Total Liabilities 86.3 Million 165.18 Million 476.43 Million 652.76 Million 727.68 Million 751.85 Million
Total Current Liabilities 16.78 Million 98.81 Million 41.66 Million 100.11 Million 17 Million 82.24 Million
Account Payables 2.42 Million 5.3 Million 8.4 Million 3.78 Million 2.42 Million 4.18 Million
Tax Payables - - 6.19 Million - - -
Short Term Debt 410 Thousand 77.41 Million 1.41 Million 8.47 Million 1.24 Million 26.43 Million
Deferred Revenue 1.22 Million 355 Thousand 654 Thousand 29.43 Million 2.13 Million 3.28 Million
Other Current Liabilities 12.72 Million 15.73 Million 31.19 Million 58.41 Million 11.2 Million 48.34 Million
Total Non Current Liabilities 69.52 Million 66.37 Million 434.76 Million 552.64 Million 710.68 Million 669.6 Million
Long-Term Debt 5.75 Million - 320.71 Million 442.29 Million 638.95 Million 609.86 Million
Deferred Revenue Non Current 1.44 Million - 59.09 Million -512.53 Million 9.97 Million -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 30.7 Million 35.75 Million 24.09 Million 558.29 Million 28.81 Million 7.77 Million
Other Liabilities - 1.00 1.00 - - -
Total Equity 700.91 Million 597.48 Million 821.15 Million 709.52 Million 767.23 Million 560.91 Million
Stock Holders Equity 700.91 Million 597.48 Million 821.15 Million 709.52 Million 767.23 Million 560.91 Million
Common Stock 18 Thousand 17 Thousand 17 Thousand 16 Thousand 17 Thousand 21 Thousand
Retained Earnings 503.01 Million 450.86 Million 449.09 Million 391.95 Million 400.1 Million -229.19 Million
Accumulated other comprehensive income -817 Thousand -984 Thousand -917 Thousand -801 Thousand -215.99 Thousand -1.02 Million
Common Stock Equity 700.91 Million 597.48 Million 821.15 Million 709.52 Million 767.23 Million 560.91 Million
Capital Lease Obligation 5.75 Million 10.33 Million 2.25 Million 5.64 Million 9.97 Million -
Total Investments 195.67 Million 166.86 Million 321.58 Million 363.56 Million 998.32 Million 647.4 Million
Total Debt 6.16 Million 87.74 Million 324.38 Million 456.41 Million 650.17 Million 636.29 Million
Net Debt -16.78 Million 42.74 Million 304.86 Million 408.45 Million 577.89 Million 516.51 Million

Balance Sheet Charts